The Stimulant Balance: Treating ADHD in the Context of Substance Use- Virtual Training

Registration and More information

Description

This training will provide participants with the tools for identifying ADD/ADHD among patients. Commonly used stimulant medications for treating ADD/ADHD will be covered, including their importance, potential side effects, and treatment considerations. Participants will gain tools for evaluating the effectiveness of ADHD treatment interventions.

Intended audience

Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.

Speakers

Megan (Meg) Hudson, MSN, PMHNP-BC (she/her)

Meg is a clinical nurse educator with Boston Medical Center’s (BMC) Grayken Center for Addiction Training and Technical Assistance and a psychiatric mental health nurse practitioner at Boston Medical Center. Prior to obtaining her MSN, she worked as a nurse care manager in the Stimulant Treatment and Recovery Clinic (START) clinic, integrating harm reduction, infectious disease treatment, medical addiction groups, and co-management of stimulant use disorders and mental health conditions. Her clinical expertise includes harm reduction, low barrier treatment, complex care management, early identification and management of acute and persistent stimulant-induced psychosis. She earned both her BSN and MSN from Regis College.

Objectives

At the end of this training, participants will have the knowledge necessary to:

• Recognize the use of screening tools to identify patients with ADD/ADHD.
• Recognize the importance of treating ADD/ADHD in patients with substance use disorder (SUD).
• Describe at least two commonly used stimulant medications in patients with SUD, including potential side effects and treatment considerations.
• Identify strategies to evaluate the effectiveness of treatment interventions for ADHD.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).